Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis

Journal of Rheumatology

Volumn 31, Issue 10, 2004, Pages 2068-2070

  Ramanan, Athimalaipet V ^a   Rosenblum, Norman D ^b   Feldman, Brian M ^a   Laxer, Ronald M ^a   Schneider, Rayfel ^a,c  

^a Division of Pediatric Rheumatology   (Canada)

^b Division of Pediatric Nephrology   (Brazil)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Hemophagocytic lymphohistiocytosis; Macrophage activation syndrome; Systemic onset JRA

Indexed keywords

CYCLOSPORIN; ETOPOSIDE; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

ADOLESCENT; ARTICLE; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FEVER; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY DISEASE; LIVER DYSFUNCTION; MACROPHAGE ACTIVATION SYNDROME; MALE; MORBIDITY; MORTALITY; PANCYTOPENIA; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SYSTEMIC ONSET JUVENILE RHEUMATOID ARTHRITIS; TONIC CLONIC SEIZURE;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; KIDNEY DISEASES; MACROPHAGE ACTIVATION; MALE; SYNDROME; TREATMENT OUTCOME;

EID: 5044231988     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Schneider R, Laxer RM. Systemic onset juvenile rheumatoid arthritis. Baillieres Clin Rheumatol 1998;12:245-71.
2. Wallace CA, Levinson JE. Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. Rheum Dis Clin North Am 1991;17:891-905.
3. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 1985;106:561-6.
4. Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 2001;40:1285-92.
5. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6.
6. Society W, Got H. Histiocytosis syndromes in children. Lancet 1987;1:208-9.
7. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002;14:548-52.
8. Ramanan AV, Baildam EM. Macrophage activation syndrome is hemophagocytic lymphohistiocytosis-need for the right terminology [letter]. J Rheumatol 2002;29:1105.
9. Athreya BH. Is macrophage activation syndrome a new entity? Clin Exp Rheumatol 2002;20:121-3.
10. Emmenegger U, Reimers A, Frey U, et al. Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation. Swiss Med Wkly 2002;132:230-6.
11. Reiner AP, Spivak JL. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore) 1988;67:369-88.